Le cannabidiol atténue la dysfonction cardiaque, le stress oxydatif, la fibrose, ainsi que les voies de signalisation inflammatoires et de mort cellulaire dans la cardiomyopathie diabétique

Rajesh et al. (Wed,) ont étudié cette question.

www.synapsesocial.com/papers/69f2ca1fa9949f73c77cb9b0 — DOI: https://doi.org/10.1016/j.jacc.2010.07.033

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients· 1980 · 568 citations
2. Oxidative Stress-Dependent Impairment of Cardiac-Specific Transcription Factors in Experimental Diabetes· 2006 · 142 citations
3. Human Apolipoprotein A-I Gene Transfer Reduces the Development of Experimental Diabetic Cardiomyopathy· 2008 · 104 citations
4. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy